A Systematic Review of Clinical Trials in Uveitis: Lessons Learned-Reference-Cited by-同舟云学术

A Systematic Review of Clinical Trials in Uveitis: Lessons Learned

Published:2022-10-06 Issue: Volume: Page:1-8
ISSN:0928-6586
Container-title:Ophthalmic Epidemiology
language:en
Short-container-title:Ophthalmic Epidemiology

Author:

Lobo-Chan Ann-Marie¹,Joltikov Katherine¹,Haseeb Abid¹,Mehta Supriya D.¹

Affiliation:

1. Ophthalmology and Visual Sciences, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA

Funder

National Eye Institute

Center for Clinical and Translational Science, University of Illinois at Chicago which is supported by the National Center for Advancing Translational Sciences

National Institutes of Health, through Grant Award Number

and unrestricted departmental funding from Research to Prevent Blindness

Publisher

Informa UK Limited

Subject

Ophthalmology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09286586.2022.2131837

Reference20 articles.

1. Causes and frequency of blindness in patients with intraocular inflammatory disease.

2. Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis

3. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

4. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

5. Interferon versus Methotrexate in Intermediate Uveitis With Macular Edema: Results of a Randomized Controlled Clinical Trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©;Ophthalmology and Therapy;2024-04-18

2. Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials;Expert Opinion on Emerging Drugs;2023-10-02